Product Information
DICLOFENAC 0.1% EYE DROPS is a generic product labeled by Advagen Pharma Ltd., priced at $1.7496 per ML under NDC 72888015021. Its NADAC has been published 57 times since Sep 3, 2025.
FDA first approved this application on Nov 13, 2008. Its Orange Book therapeutic-equivalence code is AT.
Strength
1 mg/mL
Manufacturer
Advagen Pharma Ltd.NDC
72888015021
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA077600FDA Approved
11/13/2008
TE Code
AT
On Market Since
4/30/2025
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC 0.1% EYE DROPS has been published 57 times since Sep 3, 2025, and over the history we have for it it has declined 4.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7496 per ML |
|---|---|
| All-time high | $1.8598 (May 13, 2026) |
| All-time low | $1.6475 (Feb 18, 2026) |
| 52-week high | $1.8598 |
| 52-week low | $1.6475 |
| Median price | $1.7747 |
| Average price | $1.7658 |
| Largest weekly change | +8.4% (Nov 19, 2025) |
| Weeks tracked | 57 |
| Tracking since | Sep 3, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DICLOFENAC SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC 0.1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC 0.1% EYE DROPS, manufactured by Advagen Pharma Ltd., is $1.7496 per ML (NDC 72888015021), effective Sep 30, 2026.
How has the price of DICLOFENAC 0.1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for DICLOFENAC 0.1% EYE DROPS has declined 4.0%. It has been tracked across 57 weekly CMS publications since Sep 3, 2025.
What are the highest and lowest recorded NADAC prices for DICLOFENAC 0.1% EYE DROPS?
Since Sep 3, 2025, the NADAC for DICLOFENAC 0.1% EYE DROPS has ranged from a low of $1.6475 (Feb 18, 2026) to a high of $1.8598 (May 13, 2026), with a median of $1.7747 per ML.
Are there cheaper alternatives to DICLOFENAC 0.1% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICLOFENAC 0.1% EYE DROPS, is $1.6954 per ML — about 3% below DICLOFENAC 0.1% EYE DROPS.
Who manufactures DICLOFENAC 0.1% EYE DROPS?
DICLOFENAC 0.1% EYE DROPS (NDC 72888015021) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.